Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia

Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Heinz Gisslinger(Medical University of Vienna), Siegfried Sormann(Medical University of Graz), Martin Schalling(Karolinska University Hospital), Michael Steurer(Innsbruck Medical University), Bettina Gisslinger(Medical University of Vienna), Wolfgang Schimetta(Johannes Kepler University of Linz), Günther Gastl(Innsbruck Medical University), Jürgen Thiele, Reinhard Ruckser(Donauspital), Maria Theresa Krauth(Medical University of Vienna), Ernst Schloegl(Hanusch Hospital)
European Journal Of Haematology
March 31, 2018
10.1111/ejh.13070
Cited by 18

Related Papers

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
|Blood|2012|596
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
|New England Journal of Medicine|1990|450
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|The Lancet Haematology|2020|351